首页 > 最新文献

AIDS Research and Therapy最新文献

英文 中文
Public health response to Mpox: Safeguarding vulnerable Key Populations and People Living with HIV in Zanzibar. 应对麻风病的公共卫生措施:保护桑给巴尔的重点弱势群体和艾滋病毒感染者。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-29 DOI: 10.1186/s12981-024-00658-9
Mansour Maulid Mshenga, Issa Abeid Mussa, Shaaban Hassan Haji

Mpox, caused by the Monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly affecting vulnerable populations. The recent outbreak in the Democratic Republic of the Congo (DRC) is the largest recorded, driven by the highly virulent clade 1 strain. Transmission has shifted from animal contact to primarily sexual contact among Key Populations (KPs) such as Sex Workers (SW) and Men who have Sex with Men (MSM). In Zanzibar, where HIV prevalence is significantly higher among Key Populations, People Living with Human Immunodeficiency Virus (PLHIV) are at increased risk of Mpox infection due to socioeconomic challenges and immunosuppression. Despite no reported cases in Zanzibar, the spread of Mpox in non-endemic areas highlights the need for proactive measures. Leveraging Zanzibar's strengthened public health infrastructure, key strategies include tailored awareness campaigns, improved vaccine access through existing COVID-19 vaccination models, healthcare infrastructure enhancement, and mental health support. These targeted actions aim to protect Zanzibar's most vulnerable populations and bolster preparedness against Mpox, emphasizing the importance of resource-appropriate interventions to mitigate potential outbreaks.

由猴痘病毒(MPXV)引起的痘病毒已成为全球公共卫生的重大问题,尤其影响到易感人群。最近在刚果民主共和国(刚果(金))爆发的疫情是有记录以来最大的一次疫情,由毒性极强的第 1 支毒株引起。在性工作者(SW)和男男性行为者(MSM)等关键人群(KPs)中,传播方式已从动物接触转变为以性接触为主。在桑给巴尔,重点人群中的艾滋病毒感染率明显较高,而人类免疫缺陷病毒感染者(PLHIV)由于社会经济困难和免疫抑制,感染 Mpox 的风险更高。尽管桑给巴尔没有病例报告,但麻疹在非流行地区的传播凸显了采取积极措施的必要性。利用桑给巴尔已得到加强的公共卫生基础设施,主要战略包括有针对性的宣传活动、通过现有的 COVID-19 疫苗接种模式改善疫苗接种、加强医疗保健基础设施以及提供心理健康支持。这些有针对性的行动旨在保护桑给巴尔最脆弱的人群,并加强对麻风腮的防备,同时强调采取与资源相匹配的干预措施以缓解潜在疫情爆发的重要性。
{"title":"Public health response to Mpox: Safeguarding vulnerable Key Populations and People Living with HIV in Zanzibar.","authors":"Mansour Maulid Mshenga, Issa Abeid Mussa, Shaaban Hassan Haji","doi":"10.1186/s12981-024-00658-9","DOIUrl":"10.1186/s12981-024-00658-9","url":null,"abstract":"<p><p>Mpox, caused by the Monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly affecting vulnerable populations. The recent outbreak in the Democratic Republic of the Congo (DRC) is the largest recorded, driven by the highly virulent clade 1 strain. Transmission has shifted from animal contact to primarily sexual contact among Key Populations (KPs) such as Sex Workers (SW) and Men who have Sex with Men (MSM). In Zanzibar, where HIV prevalence is significantly higher among Key Populations, People Living with Human Immunodeficiency Virus (PLHIV) are at increased risk of Mpox infection due to socioeconomic challenges and immunosuppression. Despite no reported cases in Zanzibar, the spread of Mpox in non-endemic areas highlights the need for proactive measures. Leveraging Zanzibar's strengthened public health infrastructure, key strategies include tailored awareness campaigns, improved vaccine access through existing COVID-19 vaccination models, healthcare infrastructure enhancement, and mental health support. These targeted actions aim to protect Zanzibar's most vulnerable populations and bolster preparedness against Mpox, emphasizing the importance of resource-appropriate interventions to mitigate potential outbreaks.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"65"},"PeriodicalIF":2.1,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults. 更正:感染艾滋病毒的成人接种 COVID-19 灭活疫苗的不良反应。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-28 DOI: 10.1186/s12981-024-00654-z
Songjie Wu, Yubin Zhang, Fangzhao Ming, Shi Zou, Mengmeng Wu, Wei Guo, Weiming Tang, Ke Liang
{"title":"Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.","authors":"Songjie Wu, Yubin Zhang, Fangzhao Ming, Shi Zou, Mengmeng Wu, Wei Guo, Weiming Tang, Ke Liang","doi":"10.1186/s12981-024-00654-z","DOIUrl":"https://doi.org/10.1186/s12981-024-00654-z","url":null,"abstract":"","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"64"},"PeriodicalIF":2.1,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals. 更正:COVID-19 灭活疫苗的免疫反应和安全性:HIV 感染者与 HIV 病毒免疫者之间的比较。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-23 DOI: 10.1186/s12981-024-00655-y
Shi Zou, Mengmeng Wu, Fangzhao Ming, Songjie Wu, Wei Guo, Gifty Marley, Zhongyuan Xing, Zhiyue Zhang, Minxia Zeng, Chao Sun, Jianfeng Zhang, Weiming Tang, Ke Liang
{"title":"Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.","authors":"Shi Zou, Mengmeng Wu, Fangzhao Ming, Songjie Wu, Wei Guo, Gifty Marley, Zhongyuan Xing, Zhiyue Zhang, Minxia Zeng, Chao Sun, Jianfeng Zhang, Weiming Tang, Ke Liang","doi":"10.1186/s12981-024-00655-y","DOIUrl":"10.1186/s12981-024-00655-y","url":null,"abstract":"","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"63"},"PeriodicalIF":2.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11421098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142306948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016–2023) 艾滋病毒耐药性:中国重庆艾滋病毒感染者的病毒基因型和变异位点分析(2016-2023 年)
IF 2.2 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-13 DOI: 10.1186/s12981-024-00646-z
Wenwan Gao, Gang Zhou, Mei Li, Pengsen Wang, Jungang Li, Renni Deng
Large-scale HIV genotype drug resistance study has not been conducted in Chongqing. A retrospective study was conducted on people living with HIV(PLWH) who received HIV-1 genotype resistance testing at Chongqing Public Health Medical Center from May 2016 to June 2023. The HIV-1pol gene was amplified through RT-PCR and analyzed in terms of genotypic drug resistance. Of the 3015 PLWH tested for HIV-1 drug resistance, 1405 (46.6%) were resistant to at least one antiviral drug. Among non-nucleoside reverse transcriptase inhibitors (NNRTIs), 43.8% were resistant, compared to 29.5% for nucleoside reverse transcriptase inhibitors (NRTIs) and 3.4% for protease inhibitors (PIs). V179D/E and K103N/S were identified as the common mutation sites in the NNRTIs class of drugs, M184V/I and K65R/N were reported as the most common mutation sites in NRTIs, while thymidine analogue mutation (TAM) group was identified in 373 samples. L10FIV was the most common mutation in PIs. The dominant HIV-1 subtype was CRF07_BC. The high prevalence of HIV-1 drug resistance in Chongqing underscores the imperative for rigorous surveillance of the local HIV epidemic. Furthermore, TAMs are associated with HIV-1 multidrug resistance, and timely detection of drug resistance is helpful to reduce the emergence and spread of such drug-resistant strains.
重庆尚未开展大规模的HIV基因型耐药性研究。本研究对2016年5月至2023年6月期间在重庆市公共卫生医疗中心接受HIV-1基因型耐药性检测的HIV感染者(PLWH)进行了回顾性研究。通过RT-PCR扩增HIV-1pol基因并分析其基因型耐药性。在接受HIV-1耐药性检测的3015名PLWH中,有1405人(46.6%)对至少一种抗病毒药物产生耐药性。在非核苷类逆转录酶抑制剂(NNRTIs)中,43.8%的人对其产生耐药性,而核苷类逆转录酶抑制剂(NRTIs)和蛋白酶抑制剂(PIs)的耐药性分别为29.5%和3.4%。V179D/E和K103N/S被确定为NNRTIs类药物中常见的突变位点,M184V/I和K65R/N被报告为NRTIs中最常见的突变位点,而在373个样本中发现了胸苷类似物突变(TAM)群。L10FIV 是 PIs 中最常见的突变。主要的 HIV-1 亚型是 CRF07_BC。重庆 HIV-1 耐药性的高流行率凸显了对当地 HIV 流行进行严格监测的必要性。此外,TAMs 与 HIV-1 多药耐药性有关,及时发现耐药性有助于减少此类耐药株的出现和传播。
{"title":"HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016–2023)","authors":"Wenwan Gao, Gang Zhou, Mei Li, Pengsen Wang, Jungang Li, Renni Deng","doi":"10.1186/s12981-024-00646-z","DOIUrl":"https://doi.org/10.1186/s12981-024-00646-z","url":null,"abstract":"Large-scale HIV genotype drug resistance study has not been conducted in Chongqing. A retrospective study was conducted on people living with HIV(PLWH) who received HIV-1 genotype resistance testing at Chongqing Public Health Medical Center from May 2016 to June 2023. The HIV-1pol gene was amplified through RT-PCR and analyzed in terms of genotypic drug resistance. Of the 3015 PLWH tested for HIV-1 drug resistance, 1405 (46.6%) were resistant to at least one antiviral drug. Among non-nucleoside reverse transcriptase inhibitors (NNRTIs), 43.8% were resistant, compared to 29.5% for nucleoside reverse transcriptase inhibitors (NRTIs) and 3.4% for protease inhibitors (PIs). V179D/E and K103N/S were identified as the common mutation sites in the NNRTIs class of drugs, M184V/I and K65R/N were reported as the most common mutation sites in NRTIs, while thymidine analogue mutation (TAM) group was identified in 373 samples. L10FIV was the most common mutation in PIs. The dominant HIV-1 subtype was CRF07_BC. The high prevalence of HIV-1 drug resistance in Chongqing underscores the imperative for rigorous surveillance of the local HIV epidemic. Furthermore, TAMs are associated with HIV-1 multidrug resistance, and timely detection of drug resistance is helpful to reduce the emergence and spread of such drug-resistant strains.","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"1 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142221019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers. 更正:乌干达感染艾滋病毒的儿童和青少年开始并完成结核病预防治疗的促进因素和障碍:对青少年、看护人和卫生工作者的定性研究。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-06 DOI: 10.1186/s12981-024-00651-2
Pauline Mary Amuge, Denis Ndekezi, Moses Mugerwa, Dickson Bbuye, Diana Antonia Rutebarika, Lubega Kizza, Christine Namugwanya, Angella Baita, Peter James Elyanu, Patricia Nahirya Ntege, Dithan Kiragga, Carol Birungi, Adeodata Rukyalekere Kekitiinwa, Agnes Kiragga, Moorine Peninah Sekadde, Nicole Salazar-Austin, Anna Maria Mandalakas, Philippa Musoke
{"title":"Correction: Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.","authors":"Pauline Mary Amuge, Denis Ndekezi, Moses Mugerwa, Dickson Bbuye, Diana Antonia Rutebarika, Lubega Kizza, Christine Namugwanya, Angella Baita, Peter James Elyanu, Patricia Nahirya Ntege, Dithan Kiragga, Carol Birungi, Adeodata Rukyalekere Kekitiinwa, Agnes Kiragga, Moorine Peninah Sekadde, Nicole Salazar-Austin, Anna Maria Mandalakas, Philippa Musoke","doi":"10.1186/s12981-024-00651-2","DOIUrl":"10.1186/s12981-024-00651-2","url":null,"abstract":"","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"61"},"PeriodicalIF":2.1,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142144938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motivation, responsibilities, and experiences of HIV/AIDS counselors in the Volta Region of Ghana: a descriptive phenomenological study. 加纳沃尔特地区艾滋病毒/艾滋病顾问的动机、责任和经验:一项描述性现象学研究。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-31 DOI: 10.1186/s12981-024-00648-x
Festus Dwomoh, Mbuyiselo Douglas, Veronica O Charles-Unadike, Joyce Komesuor, Emmanuel Manu

Background: The provision of professional counseling services for persons living with human immunodeficiency virus (PLHIV) is crucial in the prevention and treatment continuum of the disease. However, for counselors of people infected with the human immunodeficiency virus (HIV) leading to acquired immune deficiency syndrome (AIDS) to give their best, their motivations to become counselors and the challenges they face in their line of duty need to be contextually understood and addressed. We ascertained the roles, motivations, and experiences of HIV/AIDS counselors in the Volta Region of Ghana to inform HIV/AIDS counseling decision-making in the region and the country.

Methods: A phenomenological study conducted among sixteen (16) HIV/AIDS counselors from five HIV/AIDS sentinel sites in the Volta region of Ghana, recruited through a purposive sampling approach and interviewed to ascertain their HIV/AIDS counseling-related experiences. The data were thematically analyzed using the Atlas. ti software, and sub-themes supported with verbatim quotes.

Results: Five motives for becoming an HIV/AIDS counselor were found. These include being randomly assigned to the unit, developing interest in the job, because of the status of a relative, witnessing bad attitudes of healthcare providers, and seeing HIV- clients lacking knowledge of the condition. The study found that these counselors performed six core roles: providing nutritional counseling, educating clients on HIV, treatment, and medication provision, conducting testing and comprehensive counseling of clients, providing social support to clients, and offering financial support to clients. The experiences these counselors had were boosting clients' health status, counseling clients back to a normal mental state, cooperation from clients, participants gaining knowledge on HIV through counseling, counseling clients to accept their status, and when a client delivered an HIV-negative baby. Their negative experiences included clients denying their HIV status, clients defaulting on their treatment, uncooperative clients, death of clients due to fear of breach of confidentiality, self-stigmatization among clients, and the myths some people hold towards HIV/AIDS.

Conclusion: By organizing capacity-building training programs for HIV/AIDS counselors in the Volta region and addressing the negative experiences they encounter, they could be empowered to provide effective counseling, curative, and social services to people living with HIV in the region, leading to improved health outcomes.

背景:为人类免疫缺陷病毒感染者(PLHIV)提供专业的咨询服务对于该疾病的持续预防和治疗至关重要。然而,要使感染人类免疫缺陷病毒(HIV)并导致获得性免疫缺陷综合征(AIDS)的咨询师尽其所能,就需要了解和解决他们成为咨询师的动机以及他们在工作中面临的挑战。我们确定了加纳沃尔特地区艾滋病顾问的角色、动机和经验,以便为该地区和全国的艾滋病顾问决策提供信息:对加纳沃尔特地区五个艾滋病毒/艾滋病监测点的十六(16)名艾滋病毒/艾滋病咨询师进行了现象学研究,这些咨询师是通过有目的的抽样方法招募的,通过访谈了解了他们与艾滋病毒/艾滋病咨询相关的经历。使用 Atlas.ti 软件对数据进行了主题分析,并用逐字引文支持次主题:结果:发现了成为艾滋病咨询师的五个动机。这些动机包括:被随机分配到该单位、对该工作产生兴趣、因为亲属的状况、目睹医疗服务提供者的不良态度以及看到对艾滋病缺乏了解的客户。研究发现,这些咨询师履行了六项核心职责:提供营养咨询、对客户进行艾滋病、治疗和药物提供方面的教育、对客户进行检测和综合咨询、为客户提供社会支持以及为客户提供经济支持。这些咨询师的经验包括:提高服务对象的健康状况、辅导服务对象恢复正常的精神状态、服务对象的合作、参与者通过咨询获得有关艾滋病的知识、辅导服务对象接受自己的状况,以及当服务对象产下一名艾滋病阴性婴儿时。他们的负面经验包括客户否认自己的艾滋病感染状况、客户不接受治疗、客户不合作、客户因担心泄密而死亡、客户的自我污名化以及一些人对艾滋病毒/艾滋病的误解:通过为沃尔塔地区的艾滋病毒/艾滋病咨询师组织能力建设培训计划,并解决他们遇到的负面经验,可以增强他们的能力,为该地区的艾滋病毒感染者提供有效的咨询、治疗和社会服务,从而改善健康状况。
{"title":"Motivation, responsibilities, and experiences of HIV/AIDS counselors in the Volta Region of Ghana: a descriptive phenomenological study.","authors":"Festus Dwomoh, Mbuyiselo Douglas, Veronica O Charles-Unadike, Joyce Komesuor, Emmanuel Manu","doi":"10.1186/s12981-024-00648-x","DOIUrl":"10.1186/s12981-024-00648-x","url":null,"abstract":"<p><strong>Background: </strong>The provision of professional counseling services for persons living with human immunodeficiency virus (PLHIV) is crucial in the prevention and treatment continuum of the disease. However, for counselors of people infected with the human immunodeficiency virus (HIV) leading to acquired immune deficiency syndrome (AIDS) to give their best, their motivations to become counselors and the challenges they face in their line of duty need to be contextually understood and addressed. We ascertained the roles, motivations, and experiences of HIV/AIDS counselors in the Volta Region of Ghana to inform HIV/AIDS counseling decision-making in the region and the country.</p><p><strong>Methods: </strong>A phenomenological study conducted among sixteen (16) HIV/AIDS counselors from five HIV/AIDS sentinel sites in the Volta region of Ghana, recruited through a purposive sampling approach and interviewed to ascertain their HIV/AIDS counseling-related experiences. The data were thematically analyzed using the Atlas. ti software, and sub-themes supported with verbatim quotes.</p><p><strong>Results: </strong>Five motives for becoming an HIV/AIDS counselor were found. These include being randomly assigned to the unit, developing interest in the job, because of the status of a relative, witnessing bad attitudes of healthcare providers, and seeing HIV- clients lacking knowledge of the condition. The study found that these counselors performed six core roles: providing nutritional counseling, educating clients on HIV, treatment, and medication provision, conducting testing and comprehensive counseling of clients, providing social support to clients, and offering financial support to clients. The experiences these counselors had were boosting clients' health status, counseling clients back to a normal mental state, cooperation from clients, participants gaining knowledge on HIV through counseling, counseling clients to accept their status, and when a client delivered an HIV-negative baby. Their negative experiences included clients denying their HIV status, clients defaulting on their treatment, uncooperative clients, death of clients due to fear of breach of confidentiality, self-stigmatization among clients, and the myths some people hold towards HIV/AIDS.</p><p><strong>Conclusion: </strong>By organizing capacity-building training programs for HIV/AIDS counselors in the Volta region and addressing the negative experiences they encounter, they could be empowered to provide effective counseling, curative, and social services to people living with HIV in the region, leading to improved health outcomes.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"60"},"PeriodicalIF":2.1,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11365179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers. 乌干达感染艾滋病毒的儿童和青少年开始并完成结核病预防治疗的促进因素和障碍:一项针对青少年、看护人和卫生工作者的定性研究。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-29 DOI: 10.1186/s12981-024-00643-2
Pauline Mary Amuge, Denis Ndekezi, Moses Mugerwa, Dickson Bbuye, Diana Antonia Rutebarika, Lubega Kizza, Christine Namugwanya, Angella Baita, Peter James Elyanu, Patricia Nahirya Ntege, Dithan Kiragga, Carol Birungi, Adeodata Rukyalekere Kekitiinwa, Agnes Kiragga, Moorine Peninah Sekadde, Nicole-Austin Salazar, Anna Maria Mandalakas, Philippa Musoke

Introduction: People living with HIV (PLHIV) have a 20-fold risk of tuberculosis (TB) disease compared to HIV-negative people. In 2021, the uptake of TB preventive treatment among the children and adolescents living with HIV at the Baylor-Uganda HIV clinic was 45%, which was below the national target of 90%. Minimal evidence documents the enablers and barriers to TB preventive treatment (TPT) initiation and completion among children and adolescents living with HIV(CALHIV). We explored the facilitators and barriers to TPT initiation and completion among CALHIV among adolescents aged 10-19years and caretakers of children below 18years.

Methods: We conducted a qualitative study from February 2022 to March 2023, at three paediatric and adolescent HIV treatment centers in Uganda. In-depth interviews were conducted at TPT initiation and after completion for purposively selected health workers, adolescents aged 10-19 years living with HIV, and caretakers of children aged below 18years.

Results: The desire to avoid TB disease, previous TB treatment, encouragement from family members, and ministry of health policies emerged as key facilitators for the children and adolescents to initiate TPT. Barriers to TPT initiation included; TB and HIV-related stigma, busy carer and adolescent work schedules, reduced social support from parents and family, history of drug side effects, high pill burden and fatigue, and perception of not being ill. TPT completion was enabled by combined TPT and ART refill visits, delivery of ART and TPT within the community, and continuous education and counseling from health workers. Reported barriers to TPT completion included TB and HIV-related stigma, long waiting time. Non-disclosure of HIV status by caretakers to CALHIV and fear of side effects was cited by health workers as a barrier to starting TPT. Facilitators of TPT initiation and completion reported by healthcare workers included patient and caretaker health education, counselling about benefits of TPT and risk of TB disease, having same appointment for TPT and ART refill to reduce patient waiting time, adolescent-friendly services, and appointment reminder phone calls.

Conclusion: The facilitators and barriers of TPT initiation and completion among CALHIV span from individual, to health system and structural factors. Health education about benefits of TPT and risk of TB, social support, adolescent-friendly services, and joint appointments for TPT and ART refill are major facilitators of TPT initiation and completion among CALHIV in Uganda.

导言:艾滋病毒感染者(PLHIV)罹患结核病(TB)的风险是艾滋病毒阴性者的 20 倍。2021 年,贝勒-乌干达艾滋病诊所中感染艾滋病毒的儿童和青少年接受结核病预防治疗的比例为 45%,低于 90% 的国家目标。关于儿童和青少年艾滋病病毒感染者(CALHIV)开始和完成结核病预防治疗(TPT)的促进因素和障碍的证据极少。我们探讨了 10-19 岁感染艾滋病毒的儿童和青少年以及 18 岁以下儿童的看护者开始和完成结核病预防治疗的促进因素和障碍:我们于 2022 年 2 月至 2023 年 3 月在乌干达的三个儿科和青少年 HIV 治疗中心开展了一项定性研究。我们在TPT启动时和完成后对特意挑选的卫生工作者、10-19岁的青少年艾滋病感染者和18岁以下儿童的看护者进行了深入访谈:结果:避免结核病的愿望、以前接受过结核病治疗、家庭成员的鼓励以及卫生部的政策是儿童和青少年开始 TPT 的主要促进因素。启动 TPT 的障碍包括:与结核病和 HIV 相关的污名化、照顾者和青少年工作繁忙、父母和家人的社会支持减少、药物副作用史、药片负担重和疲劳,以及认为自己没有生病。将 TPT 和抗逆转录病毒疗法(ART)复诊结合起来、在社区内提供抗逆转录病毒疗法和 TPT 以及卫生工作者的持续教育和咨询都有助于完成 TPT。据报告,完成 TPT 的障碍包括与结核病和 HIV 相关的污名化、等待时间长。卫生工作者认为,护理人员不向 CALHIV 透露 HIV 感染状况以及害怕副作用也是开始 TPT 的障碍之一。医护人员报告的促进开始和完成 TPT 的因素包括:对患者和护理人员进行健康教育、提供有关 TPT 的益处和结核病风险的咨询、为 TPT 和抗逆转录病毒疗法补液安排相同的预约时间以减少患者的等待时间、提供青少年友好型服务以及拨打预约提醒电话:结论:CALHIV 启动和完成 TPT 的促进因素和障碍既有个人因素,也有医疗系统和结构性因素。在乌干达,有关 TPT 的益处和结核病风险的健康教育、社会支持、青少年友好型服务以及 TPT 和抗逆转录病毒疗法补液的联合预约是促进 CALHIV 开始和完成 TPT 的主要因素。
{"title":"Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.","authors":"Pauline Mary Amuge, Denis Ndekezi, Moses Mugerwa, Dickson Bbuye, Diana Antonia Rutebarika, Lubega Kizza, Christine Namugwanya, Angella Baita, Peter James Elyanu, Patricia Nahirya Ntege, Dithan Kiragga, Carol Birungi, Adeodata Rukyalekere Kekitiinwa, Agnes Kiragga, Moorine Peninah Sekadde, Nicole-Austin Salazar, Anna Maria Mandalakas, Philippa Musoke","doi":"10.1186/s12981-024-00643-2","DOIUrl":"10.1186/s12981-024-00643-2","url":null,"abstract":"<p><strong>Introduction: </strong>People living with HIV (PLHIV) have a 20-fold risk of tuberculosis (TB) disease compared to HIV-negative people. In 2021, the uptake of TB preventive treatment among the children and adolescents living with HIV at the Baylor-Uganda HIV clinic was 45%, which was below the national target of 90%. Minimal evidence documents the enablers and barriers to TB preventive treatment (TPT) initiation and completion among children and adolescents living with HIV(CALHIV). We explored the facilitators and barriers to TPT initiation and completion among CALHIV among adolescents aged 10-19years and caretakers of children below 18years.</p><p><strong>Methods: </strong>We conducted a qualitative study from February 2022 to March 2023, at three paediatric and adolescent HIV treatment centers in Uganda. In-depth interviews were conducted at TPT initiation and after completion for purposively selected health workers, adolescents aged 10-19 years living with HIV, and caretakers of children aged below 18years.</p><p><strong>Results: </strong>The desire to avoid TB disease, previous TB treatment, encouragement from family members, and ministry of health policies emerged as key facilitators for the children and adolescents to initiate TPT. Barriers to TPT initiation included; TB and HIV-related stigma, busy carer and adolescent work schedules, reduced social support from parents and family, history of drug side effects, high pill burden and fatigue, and perception of not being ill. TPT completion was enabled by combined TPT and ART refill visits, delivery of ART and TPT within the community, and continuous education and counseling from health workers. Reported barriers to TPT completion included TB and HIV-related stigma, long waiting time. Non-disclosure of HIV status by caretakers to CALHIV and fear of side effects was cited by health workers as a barrier to starting TPT. Facilitators of TPT initiation and completion reported by healthcare workers included patient and caretaker health education, counselling about benefits of TPT and risk of TB disease, having same appointment for TPT and ART refill to reduce patient waiting time, adolescent-friendly services, and appointment reminder phone calls.</p><p><strong>Conclusion: </strong>The facilitators and barriers of TPT initiation and completion among CALHIV span from individual, to health system and structural factors. Health education about benefits of TPT and risk of TB, social support, adolescent-friendly services, and joint appointments for TPT and ART refill are major facilitators of TPT initiation and completion among CALHIV in Uganda.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"59"},"PeriodicalIF":2.1,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of survival time for HIV/AIDS patients in the pastoralist region of Borena: a study at Yabelo General Hospital, South East Ethiopia. 博雷纳牧区艾滋病毒/艾滋病患者存活时间的决定因素:埃塞俄比亚东南部亚贝洛综合医院的一项研究。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-28 DOI: 10.1186/s12981-024-00644-1
Galgalo Jaba Nura, Kumbi Sara Wario, Markos Abiso Erango

Introduction: HIV/AIDS is one of the most dangerous diseases globally, impacting public health, economics, society, political issues, and communities. As of 2023, the World Health Organization estimates that 40.4 million people are living with HIV/AIDS. This study aimed to identify the determinants of survival time for HIV/AIDS patients in the pastoralist region of Borena at Yabelo General Hospital.

Method: The study design was a retrospective cohort study, with a sample size of 293 individuals living with HIV/AIDS, based on recorded data. This research utilized survival model analysis, employing Kaplan-Meier plots, the log-rank test, and Cox proportional hazard model analysis.

Result: Out of the total sample size, 179 (61.1%) were female and 114 (38.1%) were male. Among these males, 36 (31.6%) were deceased. The analysis using the Cox proportional hazard model revealed that the following variables were significantly associated with the survival time of HIV/AIDS patients: gender, educational status, area of residence, tuberculosis (TB), and opportunistic infections.

Conclusions: We concluded that individuals living with HIV/AIDS in urban areas have a lower risk of death compared to those in rural areas, indicating that rural residents have a reduced survival probability. Therefore, the Borena zone administration should focus on adult patients to enhance life expectancy.

导言:艾滋病毒/艾滋病是全球最危险的疾病之一,影响着公共卫生、经济、社会、政治问题和社区。据世界卫生组织估计,截至 2023 年,将有 4040 万人感染艾滋病毒/艾滋病。本研究旨在确定亚贝洛综合医院博雷纳牧区艾滋病毒/艾滋病患者存活时间的决定因素:研究设计为回顾性队列研究,根据记录的数据,样本量为 293 名艾滋病毒/艾滋病感染者。本研究采用卡普兰-梅耶图、对数秩检验和考克斯比例危险模型分析等生存模型进行分析:在所有样本中,179 人(61.1%)为女性,114 人(38.1%)为男性。在这些男性中,有 36 人(31.6%)已经死亡。使用 Cox 比例危险模型进行的分析表明,以下变量与艾滋病病毒/艾滋病患者的存活时间显著相关:性别、教育状况、居住地区、结核病(TB)和机会性感染:我们得出的结论是,与农村地区的艾滋病毒/艾滋病感染者相比,城市地区的艾滋病毒/艾滋病感染者的死亡风险较低,这表明农村居民的生存概率较低。因此,博雷纳区政府应重点关注成年患者,以提高他们的预期寿命。
{"title":"Determinants of survival time for HIV/AIDS patients in the pastoralist region of Borena: a study at Yabelo General Hospital, South East Ethiopia.","authors":"Galgalo Jaba Nura, Kumbi Sara Wario, Markos Abiso Erango","doi":"10.1186/s12981-024-00644-1","DOIUrl":"10.1186/s12981-024-00644-1","url":null,"abstract":"<p><strong>Introduction: </strong>HIV/AIDS is one of the most dangerous diseases globally, impacting public health, economics, society, political issues, and communities. As of 2023, the World Health Organization estimates that 40.4 million people are living with HIV/AIDS. This study aimed to identify the determinants of survival time for HIV/AIDS patients in the pastoralist region of Borena at Yabelo General Hospital.</p><p><strong>Method: </strong>The study design was a retrospective cohort study, with a sample size of 293 individuals living with HIV/AIDS, based on recorded data. This research utilized survival model analysis, employing Kaplan-Meier plots, the log-rank test, and Cox proportional hazard model analysis.</p><p><strong>Result: </strong>Out of the total sample size, 179 (61.1%) were female and 114 (38.1%) were male. Among these males, 36 (31.6%) were deceased. The analysis using the Cox proportional hazard model revealed that the following variables were significantly associated with the survival time of HIV/AIDS patients: gender, educational status, area of residence, tuberculosis (TB), and opportunistic infections.</p><p><strong>Conclusions: </strong>We concluded that individuals living with HIV/AIDS in urban areas have a lower risk of death compared to those in rural areas, indicating that rural residents have a reduced survival probability. Therefore, the Borena zone administration should focus on adult patients to enhance life expectancy.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"58"},"PeriodicalIF":2.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11360864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142091415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney transplant recipient with history of HIV, HBV, and past HCV infection. 有 HIV、HBV 和既往 HCV 感染史的肾移植受者。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-26 DOI: 10.1186/s12981-024-00647-y
José Ignacio Cerrillos-Gutiérrez, Ricardo Parra-Guerra, Alfredo Gutiérrez-Govea, Jorge Andrade-Sierra, Eduardo González-Espinoza, Daniel Nuño-Díaz, Martha Jessica Herrera-Rodríguez, Maribel Ávila-Morán, Ana Luisa Corona-Nakamura, Luz Yasmin Hinogiante-Segura, Claudia Alejandra Mendoza-Cerpa

Chronic viral infections caused by the human immunodeficiency virus (HIV), hepatitis C (HCV), and hepatitis B (HBV) are common among patients with end-stage renal disease (ESKD). These infections were once considered contraindications to kidney transplantation due to potential risks associated with long-term immunosuppression. Improved management and antiviral therapies have changed the prognosis and survival of this group of patients, along with an increased experience in transplanting people with these viral infections. We report the first successful kidney transplant in an ESKD patient on hemodialysis with a history of concomitant HIV, HCV and HBV infection in Mexico.

人类免疫缺陷病毒(HIV)、丙型肝炎(HCV)和乙型肝炎(HBV)引起的慢性病毒感染在终末期肾病(ESKD)患者中很常见。由于长期免疫抑制的潜在风险,这些感染曾一度被视为肾移植的禁忌症。随着管理和抗病毒疗法的改进,这类患者的预后和存活率都有了很大的提高,同时对这些病毒感染者进行移植的经验也在不断增加。我们报告了墨西哥首例成功进行肾移植的 ESKD 患者,该患者正在进行血液透析,并同时有 HIV、HCV 和 HBV 感染史。
{"title":"Kidney transplant recipient with history of HIV, HBV, and past HCV infection.","authors":"José Ignacio Cerrillos-Gutiérrez, Ricardo Parra-Guerra, Alfredo Gutiérrez-Govea, Jorge Andrade-Sierra, Eduardo González-Espinoza, Daniel Nuño-Díaz, Martha Jessica Herrera-Rodríguez, Maribel Ávila-Morán, Ana Luisa Corona-Nakamura, Luz Yasmin Hinogiante-Segura, Claudia Alejandra Mendoza-Cerpa","doi":"10.1186/s12981-024-00647-y","DOIUrl":"10.1186/s12981-024-00647-y","url":null,"abstract":"<p><p>Chronic viral infections caused by the human immunodeficiency virus (HIV), hepatitis C (HCV), and hepatitis B (HBV) are common among patients with end-stage renal disease (ESKD). These infections were once considered contraindications to kidney transplantation due to potential risks associated with long-term immunosuppression. Improved management and antiviral therapies have changed the prognosis and survival of this group of patients, along with an increased experience in transplanting people with these viral infections. We report the first successful kidney transplant in an ESKD patient on hemodialysis with a history of concomitant HIV, HCV and HBV infection in Mexico.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"57"},"PeriodicalIF":2.1,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Level of knowledge and intention to use oral fluid HIV self-testing and associated factors among Ethiopian health care workers in southern Ethiopia. 埃塞俄比亚南部的埃塞俄比亚医护人员对使用口服液进行艾滋病毒自我检测的了解程度和意向以及相关因素。
IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-24 DOI: 10.1186/s12981-024-00642-3
Dinku Daniel, Habtamu Hasen, Yisak Sinebo, Tessema Bereku, Melese Mekuria, Zemzem Jemal, Mesganew Amare, Yitagesu Habtu

Background: The World Health Organization has recommended a new method for HIV self-testing (HIVST) using oral fluid, intending to increase HIV testing rates, and linking individuals to medical care. Healthcare workers are chief health advocates in the community who need adequate knowledge and intention to use the newly recommended HIVST approach. However, studies on awareness and the intention to use oral fluid for HIV self-testing among Ethiopian healthcare workers are limited. Therefore, this study aimed to assess healthcare workers' knowledge of and intentions to use oral fluid for HIV self-testing in Hadiya Zone public hospitals in southern Ethiopia in 2022.

Methods: We conducted a facility-based cross-sectional study among a sample of 352 healthcare workers from 1 to 30 June 2022. The data were entered into Epidata version 4.2 and exported to SPSS version 23 for analysis. We used a logistic regression model with a 95% confidence interval for the interpretation of adjusted odds ratios (AORs) with P < 0.05.

Results: Of the total participants, 40.3% had good knowledge, and 63.1% intended to use oral fluid (HIVST). Approximately 92% of healthcare workers had not received training, and 48.3% had heard about HIVST. Only 12.3% knew about the availability of the kit in hospitals, and 19.9% had ever used HIVST. Being male (AOR = 2.28; 95% CI 1.33-3.95), receiving support for the implementation of HIVST (AOR = 2.07; 95% CI 1.21-3.56), hearing about HIVST (AOR = 5.05; 95% CI 2.89-8.81), having prior experience using HIVST (AOR = 2.94; 95% CI 1.71-5.05), having a spouse or partner (AOR = 2.78; 95% CI 1.14-6.82), and having multiple sexual partners (AOR = 2.76; 95% CI 1.13-6.78) were associated with good knowledge of oral HIVST. Being aged 25-29 years (AOR = 2.54; 95% CI 1.18, 5.41), perceiving the high cost of the HIVST kit (AOR = 0.37; 95% CI 0.16-0.84), and having poor knowledge (AOR = 1.91; 95% CI 1.13-3.23) were significantly associated with the intention to use the oral fluid for HIVST.

Conclusion: This study highlights the need for technical updating training for healthcare workers to increase their knowledge of and intention to use oral fluid for HIVST. Promoting oral fluid HIVST through targeted education, supporting initiatives, and addressing cost concerns related to the testing kit may increase the uptake of oral fluid HIVST among healthcare workers.

背景:世界卫生组织推荐了一种使用口服液进行艾滋病毒自我检测(HIVST)的新方法,旨在提高艾滋病毒检测率,并将个人与医疗护理联系起来。医护人员是社区的主要健康倡导者,他们需要有足够的知识和意愿来使用新推荐的 HIVST 方法。然而,有关埃塞俄比亚医护人员使用口服液进行 HIV 自我检测的意识和意向的研究十分有限。因此,本研究旨在评估 2022 年埃塞俄比亚南部哈迪亚区公立医院的医护人员对使用口服液进行 HIV 自我检测的了解程度和意向:我们在 2022 年 6 月 1 日至 30 日期间对 352 名医护人员样本进行了一项基于设施的横断面研究。数据输入 Epidata 4.2 版,并导出到 SPSS 23 版进行分析。我们使用了一个具有 95% 置信区间的逻辑回归模型来解释调整后的几率比(AORs)和 P 结果:在所有参与者中,40.3% 的人具有良好的知识,63.1% 的人打算使用口服液(HIVST)。约 92% 的医护人员没有接受过培训,48.3% 的医护人员听说过 HIVST。只有 12.3% 的人知道医院提供该试剂盒,19.9% 的人曾经使用过 HIVST。男性(AOR = 2.28;95% CI 1.33-3.95)、在实施 HIVST 时得到支持(AOR = 2.07;95% CI 1.21-3.56)、听说过 HIVST(AOR = 5.05;95% CI 2.89-8.81)、有使用 HIVST 的经验(AOR = 2.94;95% CI 1.71-5.05)、有配偶或性伴侣(AOR = 2.78;95% CI 1.14-6.82)和有多个性伴侣(AOR = 2.76;95% CI 1.13-6.78)与对口服 HIVST 有良好了解有关。年龄在 25-29 岁(AOR = 2.54;95% CI 1.18-5.41)、认为 HIVST 检测试剂盒价格昂贵(AOR = 0.37;95% CI 0.16-0.84)和知识贫乏(AOR = 1.91;95% CI 1.13-3.23)与使用口服液进行 HIVST 检测的意愿显著相关:本研究强调了对医护人员进行技术更新培训的必要性,以提高他们对使用口服液进行 HIVST 的认识和意向。通过有针对性的教育、支持措施和解决与检测包相关的成本问题来推广口服液 HIVST,可提高医护人员对口服液 HIVST 的接受率。
{"title":"Level of knowledge and intention to use oral fluid HIV self-testing and associated factors among Ethiopian health care workers in southern Ethiopia.","authors":"Dinku Daniel, Habtamu Hasen, Yisak Sinebo, Tessema Bereku, Melese Mekuria, Zemzem Jemal, Mesganew Amare, Yitagesu Habtu","doi":"10.1186/s12981-024-00642-3","DOIUrl":"10.1186/s12981-024-00642-3","url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization has recommended a new method for HIV self-testing (HIVST) using oral fluid, intending to increase HIV testing rates, and linking individuals to medical care. Healthcare workers are chief health advocates in the community who need adequate knowledge and intention to use the newly recommended HIVST approach. However, studies on awareness and the intention to use oral fluid for HIV self-testing among Ethiopian healthcare workers are limited. Therefore, this study aimed to assess healthcare workers' knowledge of and intentions to use oral fluid for HIV self-testing in Hadiya Zone public hospitals in southern Ethiopia in 2022.</p><p><strong>Methods: </strong>We conducted a facility-based cross-sectional study among a sample of 352 healthcare workers from 1 to 30 June 2022. The data were entered into Epidata version 4.2 and exported to SPSS version 23 for analysis. We used a logistic regression model with a 95% confidence interval for the interpretation of adjusted odds ratios (AORs) with P < 0.05.</p><p><strong>Results: </strong>Of the total participants, 40.3% had good knowledge, and 63.1% intended to use oral fluid (HIVST). Approximately 92% of healthcare workers had not received training, and 48.3% had heard about HIVST. Only 12.3% knew about the availability of the kit in hospitals, and 19.9% had ever used HIVST. Being male (AOR = 2.28; 95% CI 1.33-3.95), receiving support for the implementation of HIVST (AOR = 2.07; 95% CI 1.21-3.56), hearing about HIVST (AOR = 5.05; 95% CI 2.89-8.81), having prior experience using HIVST (AOR = 2.94; 95% CI 1.71-5.05), having a spouse or partner (AOR = 2.78; 95% CI 1.14-6.82), and having multiple sexual partners (AOR = 2.76; 95% CI 1.13-6.78) were associated with good knowledge of oral HIVST. Being aged 25-29 years (AOR = 2.54; 95% CI 1.18, 5.41), perceiving the high cost of the HIVST kit (AOR = 0.37; 95% CI 0.16-0.84), and having poor knowledge (AOR = 1.91; 95% CI 1.13-3.23) were significantly associated with the intention to use the oral fluid for HIVST.</p><p><strong>Conclusion: </strong>This study highlights the need for technical updating training for healthcare workers to increase their knowledge of and intention to use oral fluid for HIVST. Promoting oral fluid HIVST through targeted education, supporting initiatives, and addressing cost concerns related to the testing kit may increase the uptake of oral fluid HIVST among healthcare workers.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"56"},"PeriodicalIF":2.1,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142054653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AIDS Research and Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1